PULM - Intrinsic Value and Financial Analysis - Pulmatrix, Inc. - IntrinsicAlpha

Pulmatrix, Inc. PULM

Healthcare - Biotechnology - NASDAQ - US

Watchlist

$ 6.56

39.6 %

$ 24 M

Market Cap

-2.2

P/E

INCOME STATEMENT

7.3 M REVENUE

Growth Rates

1Year 20.21%

3Years -16.72%

5Years 116.62%

7Years 36.30%

10Years 27.30%

-14.7 M OPERATING INCOME

Growth Rates

1Year 22.20%

3Years -195.20%

5Years 6.23%

7Years 7.20%

10Years -39.64%

-14.1 M NET INCOME

Growth Rates

1Year 25.03%

3Years 9.90%

5Years 7.24%

7Years 9.24%

10Years -39.04%

EFFICIENCY

Earnings Waterfall Pulmatrix, Inc.

Revenue	7.3 M
Cost Of Revenue	15.5 M
Gross Profit	-8.22 M
Operating Expenses	22 M
Operating Income	-14.7 M
Other Expenses	-619 K
Net Income	-14.1 M

Income Statement

Millions

	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015	Mar-2014	Mar-2013	Mar-2012
REVENUE
Revenue	7.3	6.1	5.2	12.6	7.9	0.2	0.3	0.8	1.2	0.4	0.7	0
GROSS PROFIT
Cost Of Revenue	15.5	1.5	15.4	0	12.8	13.0	10.2	10.2	7.2	6.6	8.6	0
Gross Profit	(8.2)	4.5	(10.2)	12.6	(4.9)	(12.8)	(9.9)	(9.3)	(6.0)	(6.2)	(7.9)	0
OPERATING INCOME
Operating Expenses	22.0	25.0	21.8	22.5	21.3	20.5	17.8	18.2	24.2	3.1	0.5	30 K
Selling, General and Administrative Expenses	6.5	6.8	6.4	6.9	8.5	7.5	7.6	8.0	17.0	1.7	0.3	0
Research and Development Expenses	15.5	18.2	15.4	15.6	12.8	13.0	10.2	10.2	7.2	1.4	0.3	20 K
Operating Income	(14.7)	(18.9)	(20.2)	(0.6)	(20.7)	(20.3)	(17.5)	(24.9)	(23.0)	(3.1)	(0.5)	30 K
PRE-TAX INCOME
Interest Income Expense	0	0	0	0	0	0.2	0.6	0.9	1.0	0	0	0
Total Other Income	0.6	0.1	4 K	(9.4)	96 K	(0.2)	(0.6)	(5.9)	(3.1)	(17.4)	5.3	0
Pre-Tax Income	(14.1)	(18.8)	(20.2)	(19.3)	(20.6)	(20.6)	(18.1)	(30.8)	(26.2)	(3.1)	(0.5)	30 K
NET INCOME
Tax Provision	0	(0.1)	2.3	9.2	(0.2)	68 K	62 K	(3.0)	2.2	(15.1)	(2.6)	0
Net Income	(14.1)	(18.7)	(22.5)	(28.5)	(20.4)	(20.6)	(18.1)	(27.8)	(26.2)	(3.1)	(0.5)	30 K
EPS	3.87	5.43	8.31	19.8	24.4	99.7	186	376	647	766	131	0.18